Epstein Becker Green Further Grows Health Care & Life Sciences Practice with Additions of Accomplished Attorneys

Epstein Becker Green Firm News Washington, DC (August 10, 2016)Epstein Becker Green (EBG) is pleased to announce the addition of David Florin and the return of Ted R. Mannen to the firm. Mr. Florin, an attorney well versed in the compliance and strategic environment for faculty practice plans and academic medicine, and Mr. Mannen, a veteran advisor to clients on pharmaceutical and medical device payment issues before federal agencies and Congress, join the firm’s Health Care and Life Sciences practice, in Washington, DC. 

Mr. Florin comes to EBG from Yale University’s legal team, where he had been serving as Deputy General Counsel for Health Affairs. At Yale, he was chief legal counsel for the School of Medicine and the Yale Medical Group, one of the largest multispecialty medical groups in the United States, with more than 1,700 clinical faculty members. In addition, he was counsel to Yale Health, an HMO providing care to over 50,000 members.

With more than 35 years of experience as a health law litigator and counselor, Mr. Florin has helped providers navigate a rapidly changing regulatory and reimbursement environment, including complying with the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), as well as entering into corporate and strategic affiliations as the industry continues to integrate and consolidate.  At EBG, Mr. Florin will provide strategic and legal advice to clients on contracting, acquisitions, affiliations, medical staff, and governance matters. He will also advise on health regulatory and reimbursement issues affecting the planning and structuring of health care transactions and counsel on HIPAA compliance, corporate compliance programs, and clinical trial issues.

Mr. Mannen focuses on pharmaceutical, medical technology, and other life sciences issues with a 40-year career that spans work in Congress, industry, and major law firms, including EBG.  He represents life sciences organizations on health regulatory, intelligence, policy, and legislative matters, as well as in the complex and growing area of introducing innovations into reimbursed markets.

Mr. Mannen previously served in senior positions at the organization now known as AdvaMed, an international trade association that represents health care technology companies. His positions included General Counsel and Executive Vice President responsible for Medicare and other third-party reimbursement as well as Senior Vice President, Policy & Communications. Earlier in his career, he worked on Capitol Hill as an attorney in the House Office of the Legislative Counsel, as well as an aide on Banking Committee matters to U.S. Senator Adlai E. Stevenson (IL).  The American Bar Association Journal described Mr. Mannen, in reference to his work in legislative drafting, as one of a “new breed of lawyer-lobbyist” that offers Congress “sophistication and expertise.”

“We are thrilled to have Ted return to the firm and are very pleased to welcome David to our team during this period of exceptional change in health care finance and delivery,” said Mark E. Lutes, Chair of EBG. “These two exceptional attorneys will bring keen insight, born of decades of experience, to their client engagements.”

About Epstein Becker Green

Epstein Becker & Green, P.C., is a national law firm with a primary focus on health care and life sciences; employment, labor, and workforce management; and litigation and business disputes. Founded in 1973 as an industry-focused firm, Epstein Becker Green has decades of experience serving clients in health care, financial services, retail, hospitality, and technology, among other industries, representing entities from startups to Fortune 100 companies. Operating in offices throughout the U.S. and supporting clients in the U.S. and abroad, the firm’s attorneys are committed to uncompromising client service and legal excellence. For more information, visit www.ebglaw.com.